Research location
Yantai
Shandong, China
Advertisement
Research activity in Yantai
Shandong, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 53 trials and 53 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Yantai
53 linked trials · page 1 of 2Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid ArthritisNCT07796516 · 2026-09-01 · 1 site observation
RECRUITING
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerNCT06993506 · 2026-05-28 · 1 site observation
RECRUITING
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07464587 · 2026-04-14 · 1 site observation
RECRUITING
Phase II Trial of RC1416 Injection in AsthmaNCT07403487 · 2026-03-10 · 1 site observation
RECRUITING
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid AsthmaNCT07436949 · 2026-03-02 · 1 site observation
RECRUITING
A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLCNCT07815223 · 2025-11-04 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 1 site observation
RECRUITING
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 1 site observation
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC PatientsNCT06155084 · 2023-12-26 · 1 site observation
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseNCT05908695 · 2023-08-31 · 1 site observation
RECRUITING
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung CancerNCT07485920 · 2026-05-01 · 1 site observation
NOT_YET_RECRUITING
China-NINE Cohort：Neuroimmune Network in Elderly / NeurodegenerationNCT07586501 · 2026-01-16 · 1 site observation
ENROLLING_BY_INVITATION
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)NCT07054242 · 2025-10-30 · 1 site observation
NOT_YET_RECRUITING
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerNCT06764485 · 2025-03-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).NCT06551324 · 2024-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Henagliflozin's Impact on Prediabetes RemissionNCT06448130 · 2024-06-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast CancerNCT06265428 · 2024-01-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid ArthritisNCT05849727 · 2023-08-30 · 1 site observation
TERMINATED
Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast CancerNCT05800756 · 2022-08-04 · 1 site observation
UNKNOWN
Study of KN046 in Subjects With Advanced Non-Small Cell Lung CancerNCT05420220 · 2022-07-26 · 1 site observation
COMPLETED
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)NCT05069467 · 2022-06-01 · 1 site observation
UNKNOWN
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)NCT05288166 · 2022-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)NCT05221580 · 2022-03-18 · 1 site observation
COMPLETED
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)NCT04968184 · 2021-11-05 · 1 site observation
TERMINATED
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast CancerNCT05054751 · 2021-09-10 · 1 site observation
COMPLETED
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung CancerNCT04952597 · 2021-07-15 · 1 site observation
COMPLETED
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNCT04746924 · 2021-05-24 · 1 site observation
TERMINATED
A Phase 2 Study of Hemay007 in Patients With Rheumatoid ArthritisNCT05247216 · 2021-03-26 · 1 site observation
COMPLETED
NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)NCT05375110 · 2021-03-10 · 1 site observation
UNKNOWN
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate CancerNCT04736199 · 2021-02-23 · 1 site observation
COMPLETED
Clinical Characteristics and Treatment of Chest Tightness Variant AsthmaNCT04322422 · 2020-06-01 · 1 site observation
UNKNOWN
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast CancerNCT04109066 · 2019-11-18 · 1 site observation
COMPLETED
Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung CancerNCT04102982 · 2019-11-01 · 1 site observation
UNKNOWN
Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung CancerNCT04005716 · 2019-07-22 · 1 site observation
COMPLETED
Bronchial Ablation for Treatment of Asthma (BATA) TrialNCT03765307 · 2019-06-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung CancerNCT04641754 · 2019-03-07 · 1 site observation
UNKNOWN
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerNCT03706365 · 2018-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) MetastasesNCT03653546 · 2018-10-29 · 1 site observation
COMPLETED
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and HypertensionNCT03532620 · 2018-08-09 · 1 site observation
UNKNOWN
Microwave Ablation in Ground Glass NodulesNCT03490890 · 2018-05-01 · 1 site observation
UNKNOWN
Early Management Strategies of Acute Heart Failure for Patients With NSTEMINCT03189901 · 2017-07-01 · 1 site observation
UNKNOWN
Comparison of HFNC With NIV in Weaning COPDNCT03458364 · 2017-01-01 · 1 site observation
COMPLETED
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerNCT02799602 · 2016-11-30 · 1 site observation
COMPLETED
Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLCNCT02455843 · 2015-05-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.